옵션 체인은 다양한 행사가격과 만기일에 대한 Tilray Brands의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Tilray Brands에 대한 시장 심리를 평가합니다..

Tilray Brands (NASDAQ:TLRY) 주식, 옵션 체인

Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Meta Platforms Inc.

News

Legal

Markets

Tech

Media

BABA

NVDA

TLRY

메타 플랫폼스(NASDAQ:META)는 케임브리지 애널리티카(Cambridge Analytica)의 데이터 스캔들에 대한 미국 대법원의 항소가 기각된 후 수십억 달러 규모의 소송에 직면할 예정이다.

메타, 대법원이 CA 데이터 스캔들에 대한 항소를 기각하여 수십억 달러 규모의 소송 직면

Screen Shot 2024-07-29 at 3.27.35 PM

Cannabis

Earnings

Movers

틸레이 브랜즈(NASDAQ:TLRY)는 월요일 시장 마감 후 2024 회계연도 4분기 재무 결과를 발표했다. 이번 분기의 주요 지표를 살펴보세요.

틸레이: 4분기 매출 및 EPS 예상 상회에 주가 급등, 대마초, 음료 및 웰빙의 융합을 선도

Tilray Brands Inc

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ALEAF">Aleafia Health</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALEAF#OTC">ALEAF</a>) shares closed up 900.00% at $1e-05</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 31.84% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 21.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 15.18% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 14.62% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 9.62% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 9.36% at $0.94</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 8.27% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 8.21% at $0.19</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 6.38% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 6.15% at $6.04</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 5.57% at $1.03</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 5.26% at $0.60</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 5.26% at $0.80</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed up 4.86% at $10.81</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 4.17% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 4.14% at $4.28</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.68% at $1.41</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 56.27% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 26.09% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 10.34% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 6.55% at $0.89</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 4.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 4.65% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.56% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed down 3.19% at $4.90</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 3.14% at $0.27</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

CARA

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CLSH

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CWBHF

CXXIF

FFNTF

GBHPF

GNLN

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

NWVCF

OILFF

RMHB

SOLCF

UGRO

XXII

Cannabis Stock Gainers And Losers From April 11, 2025

Another busy stretch reminded the cannabis industry that momentum rarely moves in a straight line. 
Minnesota punted its adult‑use launch to at least 2026, while Germany's new coalition left legalization intact. In Latin America, Chile pushed a sweeping adult‑use bill even as Panama tightened medical rules and Italy stunned hemp operators with a sudden ban. 
Companies stayed active: SNDL Inc. (NASDAQ: SNDL) inked a 32‑store acquisition and started trading in Canada, MariMed Inc. (OTC: MRMD) elevated a longtime brand builder to chief commercial officer and Tilray Brands Inc. (NASDAQ: TLRY) trimmed guidance after softer cannabis sales. 
Below is a recap of every headline that mattered.
<h2 class="wp-block-heading">Politics And Regulation</h2>
<h3 class="wp-block-heading">U.S. Rescheduling Could Drift Under Trump</h3>
Former DEA adviser Matt Lawrence told an Ohio State University forum that, without explicit White House backing, the DEA might "do essentially nothing at all," leaving the Schedule III proposal in limbo. Former HHS counsel Patricia Zettler added that new DEA nominee Terrance Cole's long agency tenure "doesn't bode particularly well for support of rescheduling," warning that the simplest outcome may be prolonged delay.
The discussion, reported by <a class="" href="https://www.marijuanamoment.net/former-dea-and-hhs-officials-suggest-marijuana-rescheduling-could-be-delayed-indefinitely-if-trump-doesnt-proactively-support-it/">Marijuana Moment</a>, highlighted how politics—not science—will likely dictate the timetable. Speakers also noted that DEA could revive the process quickly if President Trump deems it a priority, but the administration's first‑year drug plan omitted any reference to cannabis reform.
<h3 class="wp-block-heading">Medicare And Medicaid Draw A Hard Line</h3>
The Centers for Medicare &amp; Medicaid Services finalized a rule clarifying that "alcohol, tobacco, and cannabis products" are ineligible as supplemental benefits in Medicare Advantage plans. CMS said it had fielded questions about covering medical marijuana but reiterated that cannabis remains illegal federally.
In the same notice—slated for the Federal Register on June 3—CMS specified that CBD products also fail the "primarily health related" test, effectively barring coverage. The policy details appear in the agency's rulemaking summary, also covered by <a class="" href="https://www.marijuanamoment.net/medicare-and-medicaid-officials-finalize-rule-to-clarify-that-medical-marijuana-isnt-covered-by-federal-health-programs/">Marijuana Moment</a>.
<h3 class="wp-block-heading">Minnesota's Retail Clock Slips</h3>
Consultant Stefan Egan, who helped draft Minnesota's adult‑use law, told <a class="" href="https://kstp.com/kstp-news/top-news/minnesota-marijuana-dispensaries-might-not-open-until-late-spring-2026/">KSTP‑TV</a> that absent final rules, licenses won't be issued before late spring 2026. Sen. Mark Koran projected another nine to twelve months for build‑outs and product testing, pushing first sales into late spring or early summer 2026.
Both sources warned that uncertainty hampers investment. The Office of Cannabis Management noted more than 1,000 qualified applicants stand ready once regulations land, but it offered no firm timeline.
<h3 class="wp-block-heading">Germany Keeps CanG in Place</h3>
Germany's new CDU/CSU‑SPD coalition will not roll back the 2024 legalization law. Instead, the government plans a "neutral evaluation" in autumn 2025.
The compromise came after Bavaria's CSU pushed for reinstating prohibition. Federal drug commissioner Burkhard Blienert called the existing framework "an important contribution to a more honest and decriminalized approach to drugs," urging patience until the review.
Read the full story on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44716802/cannabis-stays-legal-in-germany-following-new-coalition-deal">Benzinga</a>
<h3 class="wp-block-heading">Chile Advances Adult‑Use Bill</h3>
A cross‑party coalition introduced legislation allowing six‑plant home‑grows, 40‑gram public possession and nonprofit cultivation clubs. Lead sponsor Ana María Gazmuri said the proposal "allows us to catch up with international standards."
Civil‑society leaders told El Planteo the bill addresses organized crime by offering legal access. Presidential contender Vlado Mirosevic pledged to champion legalization if elected, calling prohibition a "failure of drug policy."
Read the full story on <a href="https://www.benzinga.com/news/legal/25/04/44743798/chile-moves-to-legalize-adult-use-cannabis-with-backing-from-presidential-candidate">Benzinga</a>
<h3 class="wp-block-heading">Panama Regulates, Italy Prohibits</h3>
Panama's Decree No. 6 broadens physician prescribing rights but bans vaporizers, a restriction reformer Carlos Ossa called illogical because "70% of patients use vaporizers." Production licenses remain pending, so the country still relies on imports.
Only a few days before that, Italy issued an emergency decree banning all hemp and CBD flowers. Trade group Canapa Sativa Italia warned the move threatens up to 30,000 jobs and violates EU precedent that CBD is not a narcotic.
Read the full story on <a href="https://www.benzinga.com/markets/cannabis/25/04/44747982/one-step-forward-one-step-back-panama-regulates-cannabis-italy-bans-it">Benzinga</a>.
<h3 class="wp-block-heading">Netherlands Launches Supply‑Chain Pilot</h3>
Ten municipalities—including Arnhem, Groningen and Tilburg—began requiring coffeeshops to stock only state‑licensed cannabis. Hashish will follow once supply stabilizes, officials told Dutch media. Shop owner Willem Vugs welcomed the phased roll‑out, saying growers need time to "produce the right quality and variety."
The four‑year experiment, detailed by Dutch News reporting, aims to replace the decades‑old "back‑door" model where sales are tolerated but large‑scale cultivation remains illegal.
<h2 class="wp-block-heading">Corporate And Market Moves</h2>
<h3 class="wp-block-heading">SNDL Expands Retail Footprint And Lists On The CSE</h3>
SNDL Inc. agreed to buy 32 Cost Cannabis and T Cannabis stores from 1CM Inc. (CSE: EPIC) for C$32.2 million in cash, per the companies' joint release. CEO Zach George said the deal "aligns with our stated capital priorities" and boosts the network to 219 owned or franchised outlets.
The transaction—covering locations in Ontario, Alberta and Saskatchewan—generated C$53 million in revenue for 1CM's fiscal 2024. Closing is expected by Q3 2025, pending court and shareholder approval, after which 1CM plans to return "a substantial portion" of the proceeds to investors.
Two days after the acquisition announcement, SNDL began trading on the Canadian Securities Exchange under the same ticker. George said the move "creates optionality for shareholders" and positions the company to pursue growth with "greater agility."
The CSE listing allows investors to trade shares in Canadian dollars and fits the exchange's cannabis‑friendly framework, according to SNDL's statement.
<h3 class="wp-block-heading">MariMed Names Chief Commercial Officer</h3>
MariMed Inc. promoted Ryan Crandall—co‑creator of Betty's Eddies Chews—to chief commercial officer. CEO Jon Levine credited Crandall with building "our innovative and trusted portfolio of brands."
Crandall, who joined MariMed in 2018, will oversee sales, marketing, product development and retail. He called the role "a fantastic journey" and pledged to strengthen MariMed's market position.
<h3 class="wp-block-heading">Scotts Miracle‑Gro Spins Off Hawthorne Collective</h3>
The Scotts Miracle‑Gro Company (NYSE: SMG) transferred its Hawthorne Collective investment arm to an independent partner in exchange for an interest‑bearing note. CEO Jim Hagedorn said the move reduces cannabis‑sector volatility and lets Scotts focus on core lawn and garden products.
The company retains an option to reacquire Hawthorne Collective if federal reform—such as rescheduling or the SAFER Banking Act—boosts sector prospects. Hagedorn noted that "four years of unkept promises" have hampered growth.
<h3 class="wp-block-heading">Tilray Trims Revenue Outlook</h3>
Tilray Brands reported Q3 revenue of $185.8 million, down from $188.3 million a year earlier and below consensus. Cannabis sales fell to $54.3 million, while beverage alcohol rose slightly to $55.9 million.
Citing SKU rationalization and a shift of product from Canada to higher‑margin export markets, Tilray cut its FY‑2025 revenue target to $850–900 million from up to $1 billion, as detailed in <a class="" href="https://www.benzinga.com/25/04/44685827/tilray-brands-reports-lower-cannabis-sales-in-q3-trims-2025-revenue-outlook">Benzinga</a>.
<h2 class="wp-block-heading">Market Forecasts</h2>
<h3 class="wp-block-heading">Whitney Economics Slashes U.S. Sales Projections</h3>
Data firm Whitney Economics reduced its 2025–2030 U.S. retail forecast by $21.1 billion, blaming oversupply, high taxes and hemp‑derived substitutes. Founder Beau Whitney said, "Lower prices, lower participation and more substitutes will result in lower revenues."
California took the biggest hit, with a $606 million downgrade for 2025. New York and Maryland were bright spots, reflecting faster‑growing new markets. 
Read the full story on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44720279/is-legal-weed-in-trouble-analyst-says-taxes-oversupply-and-hemp-threat-drove-a-21b-cut-in-sales-estimates">Benzinga</a>.
<h2 class="wp-block-heading">Science, Education &amp; Events</h2>
<h3 class="wp-block-heading">Avicanna Calls Clinicians To Toronto</h3>
Avicanna Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AVCNF#OTC">AVCNF</a>) (TSX: AVCN) will host its fifth medical symposium—"From Emerging Evidence to Clinical Practice"—on June 6 at Toronto's MaRS Discovery District. Executive VP Dr. Karolina Urban said the gathering aims to "enhance our collective understanding of cannabinoid‑based medicines."
Speakers include researchers from Washington State, Johns Hopkins and the University of British Columbia, covering topics from CBG's therapeutic potential to opioid–cannabinoid interactions. Healthcare professionals can register or submit poster abstracts at <a class="" href="https://www.avicanna.com/symposium">avicanna.com/symposium</a>.
<h3 class="wp-block-heading">Argentina Explores Cannabis Tourism And Chemo Pain Relief</h3>
Mendoza passed a law creating a provincial cannabis registry, while entrepreneur Gonzalo Llamas Bianchetti's Proyecto Vallecitos seeks to revive an abandoned ski town with hemp‑based eco‑lodging and cultivation. Provincial health leader Daniel Llaver said the registry focuses on patient access and industry compliance.
Separately, a three‑year preclinical study by CONICET and Universidad Austral found a 1:1 CBD‑THC oral blend prevented chemotherapy‑induced neuropathic pain in rats without added toxicity. Both stories were detailed in <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44745709/from-malbec-to-marijuana-argentinas-provincial-push-fuels-cannabis-tourism-science-and-policy">Benzinga</a>.
<h2 class="wp-block-heading">Recommended Reads Of The Week</h2>
<ul>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44720917/whos-blocking-cannabis-reform-in-the-senate-marijuana-policy-remains-a-dividing-line-between-democrats-and-republicans">Who's Blocking Cannabis Reform in the Senate?</a></li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44752007/latino-entrepreneurs-are-thriving-in-nycs-cannabis-market-heres-the-proof">Latino Entrepreneurs Are Thriving in NYC's Cannabis Market—Here's the Proof</a></li>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/08/ice-t-says-he-doesnt-get-high-so-why-did-he-open-a-cannabis-dispensary-with-a-playboy-playmate/">Ice‑T Says He Doesn't Get High—So Why Did He Open a Cannabis Dispensary With a Playboy Playmate?</a></li>
</ul>
Check back next week for a new recap of what&#8217;s going on in the most exciting industry in the world. Until then, stay high(drated).

Politics

AVCNF

MRMD

SNDL

The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 35.29% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 22.70% at $0.50</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 11.07% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 10.47% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 9.09% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 7.59% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.35% at $1.36</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 4.19% at $0.51</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 4.00% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed up 3.60% at $10.71</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 55.23% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 15.00% at $0.95</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 11.56% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 8.09% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 6.48% at $7.72</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 5.98% at $48.70</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 4.82% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.30% at $0.51</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.26% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 4.13% at $50.42</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 4.00% at $7.20</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 3.98% at $4.11</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed down 3.88% at $4.87</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 3.68% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed down 3.24% at $147.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNBX

CNGGF

CPHRF

IIPR

KAYS

Cannabis Stock Gainers And Losers From April 10, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 39.74% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 25.00% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 22.70% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 19.48% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 16.81% at $0.53</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 15.05% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 15.02% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.51% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 12.49% at $0.95</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 10.29% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 10.05% at $4.26</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 9.88% at $0.90</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 9.30% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 9.09% at $52.59</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 8.91% at $1.39</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 8.62% at $151.92</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed up 7.85% at $51.80</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 7.58% at $1.38</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 7.49% at $0.90</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 6.54% at $0.58</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 6.17% at $1.72</li>
<li><a href="https://www.benzinga.com/quote/EHC">Encompass Health</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) shares closed up 5.40% at $103.20</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 5.18% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 5.03% at $8.26</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 24.86% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 8.56% at $1.07</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 7.35% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 7.08% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 3.01% at $1.55</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBRRF

CRON

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

GRWG

TGIFF

YCBD

Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025

Piper Sandler analyst Michael Lavery maintains Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) with a Neutral and lowers the price target from $2 to $1.

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on Tilray Brands, Lowers Price Target to $1

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 218.18% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 45.23% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 20.37% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 19.86% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 19.72% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 14.07% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 11.90% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 10.00% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 9.38% at $0.74</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 8.82% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 8.33% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 4.98% at $0.48</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 4.69% at $3.88</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 3.81% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.45% at $5.39</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 25.93% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 23.42% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 22.38% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 20.82% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 17.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 16.02% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 15.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 12.24% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 10.26% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 10.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 8.55% at $0.88</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 8.03% at $48.21</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 7.85% at $48.03</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed down 7.19% at $4.85</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 6.13% at $5.00</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 5.71% at $1.32</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 5.36% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 5.15% at $3.26</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 5.13% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 5.11% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.55% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 4.51% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 4.50% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 4.44% at $7.86</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 4.29% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 3.81% at $1.33</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLGVF

BLOZF

CBDY

CVSI

GTBIF

LMLLF

MGWFF

RSSFF

TCNNF

Cannabis Stock Gainers And Losers From April 8, 2025

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TLRY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.00</td>
<td>$609.6K</td>
<td>25.5K</td>
<td>4.0K</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$65.00</td>
<td>$26.4K</td>
<td>3.7K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$105.00</td>
<td>$35.7K</td>
<td>681</td>
<td>156</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TLRY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), we observe a put option sweep with bullish sentiment. It expires in 283 day(s) on January 16, 2026. Parties traded 4000 contract(s) at a $2.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $609.6K, with a price of $152.0 per contract. There were 25574 open contracts at this strike prior to today, and today 4001 contract(s) were bought and sold. 
• For CVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), we notice a put option sweep that happens to be bearish, expiring in 38 day(s) on May 16, 2025. This event was a transfer of 90 contract(s) at a $65.00 strike. This particular put needed to be split into 16 different trades to become filled. The total cost received by the writing party (or parties) was $26.4K, with a price of $294.0 per contract. There were 3731 open contracts at this strike prior to today, and today 1028 contract(s) were bought and sold. 
• Regarding NVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), we observe a put option sweep with bearish sentiment. It expires in 101 day(s) on July 18, 2025. Parties traded 55 contract(s) at a $105.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $35.7K, with a price of $650.0 per contract. There were 681 open contracts at this strike prior to today, and today 156 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

3 Health Care Stocks Whale Activity In Today's Session

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.
The Dow traded up 2.48% to 38,907.32 while the NASDAQ climbed 2.43% to 15,982.51. The S&amp;P 500 also rose, gaining, 2.38% to 5,182.79.
Check This Out: <a href="https://www.benzinga.com/25/04/44682228/wall-streets-most-accurate-analysts-spotlight-on-3-tech-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares surged by 3.7% on Tuesday.
In trading on Tuesday, utilities shares rose by just by 1.1%.
Top Headline
Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Tuesday reported better-than-expected earnings for its second quarter.
The company posted second-quarter sales of $38.59 billion, up 4.1% year over year (+4.7% on constant currency), beating the consensus of $38 billion, reflecting sales growth in the U.S. Retail Pharmacy and International segments. Adjusted EPS was 63 cents, down from $1.20 a year ago (47.5% decline), beating the consensus of 53 cents, according to data from Benzinga Pro.
Walgreens Boots Alliance withdrew its 2025 guidance under the M&amp;A deal with Sycamore Partners. The merger is expected to close in the fourth quarter of calendar year 2025.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) shares shot up 23% to $7.33 after the company announced a 20-year LNG sale and purchase agreement to supply 1.2 million tonnes per year to a subsidiary of Saudi Aramco.</li>
<li>Shares of 60 Degrees Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>)got a boost, surging 109% to $3.7395 after the company announced a patent license agreement with Yale&#8217;s School of Medicine and Public Health for the development and commercialization of Tafenoquine.</li>
<li>Cycurion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) shares were also up, gaining 37% to $0.61 after the company announced an expanded partnership with Journal Technologies and a $22 million multi-year contract with a state police agency.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares dropped 57% to $3.2291 after the company announced entry into warrant inducement transaction for approximately $3.7 million in gross proceeds.</li>
<li>Shares of Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) were down 8% to $0.5319. The company's third-quarter net revenue decreased from $188.3 million to $185.8 million, missing the consensus of $210.45 million.</li>
<li>CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) was down, falling 40% to $6.96 after Canaccord Genuity cut its price target on the stock from $23 to $18.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $61.47 while gold traded up 1.8% at $3,026.10.
Silver traded up 2.7% to $30.415 on Tuesday, while copper rose 0.8% to $4.2205.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 3.67%, Germany's DAX 40 gained 3.17% and France's CAC 40 climbed 3.54%. Spain's IBEX 35 Index rose 3.11%, while London's FTSE 100 gained 3.54%.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei 225 gaining 6.03%, China's Shanghai Composite gaining 1.58%, Hong Kong's Gang Seng index rising 1.51% and India's BSE Sensex gaining 1.49%.
Economics
The NFIB Small Business Optimism Index declined 3.3 points to a reading of 97.4 in March, recording its weakest level since October 2024 and down from market estimates of 101.3.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44682968/how-to-earn-500-a-month-from-delta-air-lines-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Delta Air Lines Stock Ahead Of Q1 Earnings</a></li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

Trading Ideas

BJDX

CVRX

CYCU

SXTP

Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings

WIIM

Tilray Brands shares are trading lower after the company reported a Q3 sales miss and cut its FY25 sales guidance.

Tilray Brands,&nbsp;Inc&#8217;s.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) third-quarter net revenue decreased from $188.3 million to $185.8 million, missing the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $210.45 million</a>.
Net revenue increased to ~$193 million on a constant currency basis. The prior-year quarter included revenue of $6 million of now-discontinued SKUs. Strategic initiatives and SKU rationalization impacted revenue by $13.2 million <a href="https://www.benzinga.com/pressreleases/25/04/g44681080/tilray-brands-reports-q3-fiscal-2025-financial-results" target="_blank" rel="noreferrer noopener">in the current year quarter</a>.
The cannabis company reported a breakeven in adjusted EPS ($0.00) compared to a consensus loss of 4 cents.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/44607064/whats-going-on-with-tilray-brands-stock-today-2" rel="noreferrer noopener">What&#8217;s Going On With Tilray Brands Stock Today?</a>
Gross profit increased by 5% to $52.0 million compared to $49.4 million in the prior year quarter. Gross margin increased 200 bps to 28% in the third quarter compared to 26% in the prior year quarter.
Adjusted EBITDA was $9.0 million compared to $10.2 million in the prior year quarter due to the beverage segment&#8217;s SKU rationalization impact of $1.0 million and $0.6 million related to the prioritization of international cannabis markets.
Beverage alcohol net revenue increased to $55.9 million, up from $54.7 million in the prior year.
Cannabis&#8217; net revenue was $54.3 million compared to $63.4 million in the prior year quarter. On a constant currency basis, Cannabis net revenue was $57.5 million.
<ul>
<li>The strategic initiative to redirect product from Canada to international markets resulted in a timing impact on revenue of $3.2 million.</li>
<li>Additionally, a strategic decision to pause presence in margin dilutive categories, such as vapes and infused pre-rolls, led to a revenue decrease of $4.0 million but prevented a potential loss exceeding $3 million.</li>
</ul>
Distribution net revenue increased 8% to $61.5 million. It was up 15% to $65.1 million on a constant currency basis.
Wellness net revenue increased 5% to $14.1 million and 8% on a constant currency basis to $14.5 million.
Tariff Update: Tilray concluded that tariffs should not impact sales.
<ul>
<li>In the U.S., Tilray&#8217;s American beverage brands are solely manufactured and distributed within the U.S. market.</li>
<li>In Canada, Tilray&#8217;s cannabis brands are produced domestically for Canadian consumers.</li>
<li>In Europe, Tilray manufactures medical cannabis brands and products for distribution across Europe and Australia.</li>
<li>Regarding Tilray&#8217;s wellness business, Manitoba Harvest is exempted from the new tariffs.</li>
</ul>
Tilray reduced outstanding total debt by $71 million. As a result, net debt to trailing twelve months EBITDA is less than 1.0x
Guidance: Tilray Brands revised its fiscal year 2025 net revenue guidance to $850 million to $900 million from prior <a target="_blank" href="https://www.benzinga.com/25/01/42914627/cannabisbeer-company-tilray-outlines-plan-to-reduce-its-beverage-portfolio-reports-mixed-q2-earnings" rel="noreferrer noopener">guidance of $950 million-$1 billion</a>.
The company said adjustments for constant currency and the impacts of the strategic initiatives and SKU rationalization, which total approximately $50 million, would have resulted in an expected net revenue of $900 million to $950 million.
Price Action: TLRY stock is up 0.12% at $0.58 during the premarket session at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44672587/eli-lilly-and-novo-nordisk-could-face-policy-shifts-as-fda-oversight-and-tariff-risks-mount-analyst" target="_blank" rel="noreferrer noopener">Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount</a></li>
</ul>
Photo: Courtesy

Guidance

Health Care

General

Tilray Brands Reports Lower Cannabis Sales In Q3, Trims 2025 Revenue Outlook

Tilray Brands Cuts FY25 Revenue Guidance From $950M - $1B To $850M - $900M Vs. $893.060M Est.

Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) reported quarterly sales of $185.78 million which missed the analyst consensus estimate of $210.45 million by 11.72 percent. This is a 1.36 percent decrease over sales of $188.34 million the same period last year.

Earnings Misses

Tilray Brands Q3 Sales $185.78M Miss $210.45M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) is expected to report quarterly loss at $0.03 per share on revenue of $209.77 million. 
• WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) is estimated to report quarterly earnings at $1.42 per share on revenue of $154.40 million. 
• Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $37.99 billion. 
• RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.50 billion. 
<h3>Companies Reporting After The Bell</h3>
• Gold Resource (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GORO#AMEX">GORO</a>) is likely to report earnings for its fourth quarter. 
• Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) is expected to report quarterly loss at $0.14 per share on revenue of $64.87 million. 
• Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) is expected to report quarterly earnings at $10.90 per share on revenue of $1.43 billion. 
• Techprecision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPCS#NASDAQ">TPCS</a>) is estimated to report earnings for its third quarter. 
• Aehr Test System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $17.76 million. 
• Mama's Creations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMA#NASDAQ">MAMA</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $31.02 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHR

CALM

GORO

KRUS

MAMA

TPCS

WDFC

Earnings Scheduled For April 8, 2025

Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) will release its quarterly earnings report on Tuesday, 2025-04-08. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Tilray Brands to report an earnings per share (EPS) of $-0.03.
Tilray Brands bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.01 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at Tilray Brands's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.01</td>
<td>-0.04</td>
<td>-0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>-0.01</td>
<td>0.04</td>
<td>0</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-10.0%</td>
<td>3.0%</td>
<td>10.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034502_0.png" alt="eps graph" />
<h3>Market Performance of Tilray Brands's Stock</h3>
Shares of Tilray Brands were trading at $0.5922 as of April 04. Over the last 52-week period, shares are down 73.12%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/TLRY/earnings">To track all earnings releases for Tilray Brands visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Tilray Brands Earnings Preview

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 30.62% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 29.43% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 25.44% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 16.95% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 10.71% at $4.80</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 7.41% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 6.82% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 5.87% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 5.41% at $0.04</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FLOOF">Flower One Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLOOF#OTC">FLOOF</a>) shares closed down 90.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 30.31% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 30.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 22.60% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 16.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 15.09% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 10.41% at $0.52</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 10.11% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 9.26% at $0.77</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 9.01% at $3.23</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 8.95% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 8.63% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 8.16% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 7.25% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 6.92% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 6.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 5.89% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 5.82% at $5.02</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed down 5.68% at $0.95</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 5.41% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.94% at $0.59</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed down 4.62% at $141.95</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 4.49% at $1.71</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.46% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 4.44% at $0.59</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 4.23% at $1.37</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 4.09% at $0.39</li>
<li><a href="https://www.benzinga.com/quote/EHC">Encompass Health</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) shares closed down 3.84% at $97.96</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 3.70% at $8.60</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 3.29% at $51.41</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNTMF

ELLXF

FLOOF

FUAPF

ZDPY

Marijuana Stock Movers For April 4, 2025

<a href="https://www.marijuanamoment.net/marijuana-rescheduling-isnt-on-the-white-houses-new-list-of-top-drug-policy-priorities-under-the-trump-administration/" title="https://www.marijuanamoment.net/marijuana-rescheduling-isnt-on-the-white-houses-new-list-of-top-drug-policy-priorities-under-the-trump-administration/">https://www.marijuanamoment.net/marijuana-rescheduling-isnt-on-the-white-houses-new-list-of-top-drug-policy-priorities-under-the-trump-administration/</a>

Macro Economic Events

Economics

AKAN

IMCC

LFLY

MAPS

MSOS

'Marijuana Rescheduling Isn't On The White House's New List Of Top Drug Policy Priorities Under The Trump Administration' - Marijuana Moment

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed up 217.50% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 47.06% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 29.82% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 8.38% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 7.45% at $4.95</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 6.52% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 6.43% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 5.56% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 4.33% at $0.19</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 71.43% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 24.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 17.30% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 16.93% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 10.00% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 9.50% at $0.98</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 8.28% at $53.16</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 7.38% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed down 7.28% at $148.82</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 7.20% at $52.42</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 6.77% at $0.62</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 6.72% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 6.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 5.76% at $0.95</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 5.10% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed down 4.60% at $0.98</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.57% at $3.55</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.56% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 4.29% at $1.57</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 4.29% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.28% at $0.62</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 3.78% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 3.71% at $1.63</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 3.49% at $0.43</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis Stock Movers For April 3, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are trading lower<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> in the morning session on Wednesday.</a>
The company has officially transitioned the cultivation of its flagship cannabis strain, Good Supply Jean Guy, to its state-of-the-art<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44603291/tilray-shifts-cultivation-of-its-flagship-canadian-cannabis-brand-and-strain-good-supply-jean-guy-" rel="noreferrer noopener"> production facility in Masson-Angers, Québec.</a>
Previously cultivated in Ontario, the cannabis strain in Québec will now benefit from the advanced technology and high-performance capabilities of the Masson-Angers facility.
This move highlights Tilray&#8217;s commitment to enhancing its operations in Québec, with the company also unveiling new packaging for the Jean Guy strain. The updated logo and packaging are set to debut on April 8, 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44605837/ryanair-soars-past-200-million-passengers-sets-new-european-record-in-air-travel" rel="noreferrer noopener">Ryanair Soars Past 200 Million Passengers In One Year, Sets New European Record In Air Travel</a>
The Masson-Angers facility, employs over 100 local residents, produces more than 12 tonnes of cannabis annually, with room for further expansion.
In addition to Jean Guy, the facility also grows other popular cannabis strains such as Grand Daddy Purps, Sweet Berry Kush, and Pineapple Express under the Good Supply brand.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 72% in the past year. Investors can gain exposure to the stock via&nbsp;AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Recently, Tilray Brands and its subsidiary HEXO Corporation announced the successful <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/03/44515743/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">dismissal of a lawsuit filed by&nbsp;Clement Italume.</a>
The Massachusetts Superior Court, Suffolk County, granted Tilray and HEXO&#8217;s motion for summary judgment, dismissing Italume&#8217;s claims.
Price Action: TLRY shares are trading lower by 1.60% to $0.6437 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44601458/teslas-european-sales-decline-for-3rd-consecutive-month-amid-china-competition-ceo-elon-musks-political-controversies" target="_blank" rel="noreferrer noopener">Tesla&#8217;s European Sales Decline For 3rd Consecutive Month Amid China Competition, CEO Elon Musk&#8217;s Political Controversies</a></li>
</ul>
Photo: Courtesy of PeopleImages.com &#8211; Yuri A via Shutterstock.

YOLO

What's Going On With Tilray Brands Stock Today?

Tilray Relocates Cultivation Of Good Supply Jean Guy To New Masson-Angers Facility In Québec

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 23.71% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 15.37% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 8.96% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 3.53% at $5.15</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 24.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 20.83% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 16.50% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 13.92% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 12.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 7.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 7.69% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 7.14% at $0.66</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 7.00% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 6.75% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 6.57% at $0.99</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 5.77% at $0.63</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 5.26% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 5.12% at $8.71</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 4.66% at $5.52</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.65% at $0.29</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 4.35% at $54.76</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 4.33% at $4.43</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 4.16% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 3.99% at $1.45</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 3.91% at $5.65</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 3.82% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 3.48% at $1.11</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 3.36% at $0.36</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 3.28% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 3.09% at $1.59</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis Stock Movers For March 28, 2025

Restaurants

Press Releases

Tilray Grows Its Non-Alcoholic Craft Beer Line, Runner's High Brewing, Across the East Coast and Mid-West Regions

Manitoba Harvest Collaborates with Whole Foods Market for Nationwide Launch of Superseed Snack Clusters

SweetWater Brewing Company and Georgia Aquarium Celebrate Third Year of Partnership with Limited Edition Aquarium-Themed Can Art for OG IPA

Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail

Tilray Successfully Prevails with Dismissal of HEXO Shareholder Lawsuit

Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

Tilray Shifts Cultivation of its Flagship Canadian Cannabis Brand and Strain, Good Supply Jean Guy, to Masson-Angers Facility in Québec

Atwater Brewery Releases Atwater Light: Detroit's Premium Light Craft Beer

Tilray Brands Reports Q3 Fiscal 2025 Financial Results

10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer

Comments

Tilray Brands

Tilray Brands (TLRY) 옵션

Tilray Brands (NASDAQ:TLRY) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌